Literature DB >> 15351743

Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.

Kengo Maeda1, Hideki Murakami, Reiko Yoshida, Masatoshi Ichihara, Akihiro Abe, Makoto Hirai, Toyoaki Murohara, Masahide Takahashi.   

Abstract

Grb2-associated binder-1 (Gab1) is a docking protein closely related to insulin receptor substrates. We previously reported that tyrosine 1062 in RET receptor tyrosine kinase activated by glial cell line-derived neurotrophic factor (GDNF) represents a binding site for the Shc-Grb2-Gab1 complex, and that the p85 subunit of phosphatidylinositol 3-kinase (PI3K) and SHP2 tyrosine phosphatase is associated with Gab1 in GDNF-treated cells. In the present study, we further analyzed the physiological roles of Gab1 downstream of RET, using Gab1 mutants that lack the binding sites for PI3K (Gab1 PI3K-m) or SHP-2 (Gab1 SHP2-m). Expression of Gab1 PI3K-m in SK-N-MC human primitive neuroectodermal tumor cells expressing wild-type RET markedly impaired Akt phosphorylation, Rac1 activation, and lamellipodia formation that were induced by GDNF whereas expression of Gab1 SHP2-m partially impaired Erk activation. Furthermore, expression of Gab1 PI3K-m, but not Gab1 SHP2-m, in TT human medullary thyroid carcinoma cells expressing RET with a multiple endocrine neoplasia 2A mutation enhanced cytochrome c release, and apoptosis induced by etoposide, suggesting that PI3K is involved in survival of TT cells via a mitochondrial pathway. These findings demonstrated that coupling of Gab1 to PI3K is important for biological responses in RET-expressing cells. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351743     DOI: 10.1016/j.bbrc.2004.08.095

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.

Authors:  Alexander Drilon; Zishuo I Hu; Gillianne G Y Lai; Daniel S W Tan
Journal:  Nat Rev Clin Oncol       Date:  2017-11-14       Impact factor: 66.675

2.  Interaction between simian virus 40 large T antigen and insulin receptor substrate 1 is disrupted by the K1 mutation, resulting in the loss of large T antigen-mediated phosphorylation of Akt.

Authors:  Yongjun Yu; James C Alwine
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

3.  NCAM-140 Translocation into Lipid Rafts Mediates the Neuroprotective Effects of GDNF.

Authors:  Li Li; Huizhen Chen; Meng Wang; Fangfang Chen; Jin Gao; Shen Sun; Yunqing Li; Dianshuai Gao
Journal:  Mol Neurobiol       Date:  2016-03-22       Impact factor: 5.590

4.  Ret-dependent and Ret-independent mechanisms of Gfl-induced sensitization.

Authors:  Brian S Schmutzler; Shannon Roy; Sherry K Pittman; Rena M Meadows; Cynthia M Hingtgen
Journal:  Mol Pain       Date:  2011-03-30       Impact factor: 3.395

5.  Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions.

Authors:  Christoph Jakob Ackermann; Gustavo Stock; Rebecca Tay; Mohammed Dawod; Fabio Gomes; Raffaele Califano
Journal:  Onco Targets Ther       Date:  2019-09-24       Impact factor: 4.147

Review 6.  Precision therapy for RET-altered cancers with RET inhibitors.

Authors:  Kyaw Z Thein; Vamsidhar Velcheti; Blaine H M Mooers; Jie Wu; Vivek Subbiah
Journal:  Trends Cancer       Date:  2021-08-12

7.  A Cross-Species Study of PI3K Protein-Protein Interactions Reveals the Direct Interaction of P85 and SHP2.

Authors:  Susanne B Breitkopf; Xuemei Yang; Michael J Begley; Meghana Kulkarni; Yu-Hsin Chiu; Alexa B Turke; Jessica Lauriol; Min Yuan; Jie Qi; Jeffrey A Engelman; Pengyu Hong; Maria I Kontaridis; Lewis C Cantley; Norbert Perrimon; John M Asara
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.